Prohost Letters
Premium
Prohost Letter #384
Prohost Letter #384 The Assassination of the Biotech Sector The Market (Part 2) On Friday September 18, 2015, the biotechnology sector occupied the news headlines for two different reasons. The first...
P
Prohost Biotech
1 min read
3
0
Unlock Premium Content
This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.
Unlimited articles
Expert analysis
Research reports
Tags
Alnylam Pharmaceuticals (ALNY)
Ariad Pharmaceuticals (ARIA)
Array BioPharma (ARRY)
BioMarin Pharmaceutical (BMRN)
bluebird bio Inc (BLUE)
Chimerix Inc (CMRX)
Exelixis (EXEL)
Gilead Sciences (GILD)
Illumina (ILMN)
ImmunoGen (IMGN)
Incyte (INCY)
Intrexon (XON)
Ionis Pharmaceuticals Inc (IONS)
Pacific Biosciences (PACB)
Portola Pharmaceuticals Inc (PTLA)
Prohost Portfolio
Sarepta Therapeutics (SRPT)
Seagen Inc (SGEN)
Spark Therapeutics
Theravance Inc (THRX)
Ziopharm Oncology (ZIOP)
Comments (0)
Please sign in to join the discussion